- Home
- TIXT vs PRTA Comparison
TIXT vs PRTA Comparison
Compare TIXT & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- PRTA
- Stock Information
- Founded
- TIXT 2005
- PRTA 2012
- Country
- TIXT Canada
- PRTA Ireland
- Employees
- TIXT N/A
- PRTA N/A
- Industry
- TIXT EDP Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- PRTA Health Care
- Exchange
- TIXT Nasdaq
- PRTA Nasdaq
- Market Cap
- TIXT 694.9M
- PRTA 809.8M
- IPO Year
- TIXT 2021
- PRTA N/A
- Fundamental
- Price
- TIXT $2.71
- PRTA $7.43
- Analyst Decision
- TIXT Hold
- PRTA Buy
- Analyst Count
- TIXT 8
- PRTA 9
- Target Price
- TIXT $4.44
- PRTA $51.71
- AVG Volume (30 Days)
- TIXT 232.0K
- PRTA 1.4M
- Earning Date
- TIXT 05-09-2025
- PRTA 05-08-2025
- Dividend Yield
- TIXT N/A
- PRTA N/A
- EPS Growth
- TIXT N/A
- PRTA N/A
- EPS
- TIXT N/A
- PRTA N/A
- Revenue
- TIXT $2,671,000,000.00
- PRTA $137,935,000.00
- Revenue This Year
- TIXT $3.72
- PRTA N/A
- Revenue Next Year
- TIXT $3.63
- PRTA $131.71
- P/E Ratio
- TIXT N/A
- PRTA N/A
- Revenue Growth
- TIXT N/A
- PRTA 54.55
- 52 Week Low
- TIXT $2.13
- PRTA $8.00
- 52 Week High
- TIXT $7.74
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- TIXT 57.76
- PRTA 24.16
- Support Level
- TIXT $2.46
- PRTA $9.37
- Resistance Level
- TIXT $2.64
- PRTA $8.80
- Average True Range (ATR)
- TIXT 0.11
- PRTA 0.67
- MACD
- TIXT 0.04
- PRTA -0.09
- Stochastic Oscillator
- TIXT 61.54
- PRTA 16.19
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).